Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, Ben-Ari Z, Heneghan MA, Harrison SA, Minuk GY, Schattenberg J, Moreno C, Vierling JM, Vincent C, Bowlus CL, Lurie Y, Muratori L, Niro G, Hirschfield G, Post AB, Zeuzen S, Welzel T, Ch'Ng C, Levy C, Miller MH, Collier JD, Corless L, Dieterich DT, Kremer A, Papatheodoridis GV, Romeo DP, Silveira MG, Bernstein DE, Naftaly-Cohen M, Floreani A, Borg B, Carey EJ, Hollywood C, Maliakkal BJ, Marzioni M, Rabinovitz M, Rupp C, Sheridan DA, Stanca CM, Swain MG, Veitsman E, Ntourakis SP, Wiesel P (2019)
Publication Type: Conference contribution
Publication year: 2019
Publisher: WILEY
City/Town: HOBOKEN
Pages Range: 777A-779A
Conference Proceedings Title: HEPATOLOGY
APA:
Huang, J.C., Invernizzi, P., Dalekos, G.N., Nevens, F., Van Vlierberghe, H., Zigmond, E.,... Wiesel, P. (2019). THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS. In HEPATOLOGY (pp. 777A-779A). Boston, MA, US: HOBOKEN: WILEY.
MLA:
Huang, Jonathan C., et al. "THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS." Proceedings of the Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA HOBOKEN: WILEY, 2019. 777A-779A.
BibTeX: Download